What is Siris Pharmaceutical Services?
Siris Pharmaceutical Services is a specialized provider of Clinical Trial Supply Management solutions, catering primarily to small and mid-sized pharmaceutical companies. The firm adeptly navigates the complexities of the clinical supply chain, addressing critical challenges related to budget constraints, timeline adherence, and quality assurance. By offering comprehensive services that include clinical packaging, secure storage, global distribution, and meticulous returns reconciliation, Siris ensures that investigational products are delivered effectively to patients. Their integrated approach to cost, time, and quality management is designed to foster successful drug development outcomes for their clients.
How much funding has Siris Pharmaceutical Services raised?
Siris Pharmaceutical Services has raised a total of $38K across 1 funding round:
Debt
$38K
Debt (2021): $38K with participation from PPP
Key Investors in Siris Pharmaceutical Services
PPP
Public-Private Partnership
What's next for Siris Pharmaceutical Services?
With the recent influx of substantial expansion capital, Siris Pharmaceutical Services is poised for accelerated growth. This financing is expected to fuel strategic initiatives aimed at enhancing its service capabilities, potentially expanding its geographical reach, and investing in technological advancements to further optimize clinical trial supply chain management. The company's focus on supporting drug development through efficient and reliable supply chain solutions positions it to capitalize on the increasing demand for specialized services in the pharmaceutical industry. Future developments will likely center on solidifying its market leadership and deepening its partnerships with pharmaceutical innovators.
See full Siris Pharmaceutical Services company page
